With the growing trend of real-world data and real-world evidence in healthcare, what can we expect moving forward? Sharon Mowen explores these applications across the product life cycle and what it means for the future of healthcare decisions.
Healthcare Perspectives
HawkPartners consultants earn their professional reputations by questioning, exploring, strategizing and analyzing. Our people post, publish and speak on a wide variety of timely marketing and research-related topics. Browse our featured posts below or select by topic from archived blog and published items. Want to discuss anything you read? We welcome the conversation.
On a Zoom with colleagues the other day, someone mentioned, “a year and a half ago, when we went into lockdown…” Has it really been that long? Apparently, it has been even longer. And for just about that entire time, we have seen valid criticisms of public health communications on the pandemic. Preparing for the […]
The emergency-use authorizations of COVID-19 vaccines are priming consumers for vaccine brand differentiation and presenting a novel marketing situation that tasks marketers with challenging master brand decisions.
During a recent Advertising Research Foundation Pharma Council event, Robert Duboff moderated a discussion of how behavioral economics can provide greater insight into the COVID-19 patient journey.
The current pandemic is tearing down the regulatory and reimbursement barriers that have prevented telehealth from realizing its full potential to date. Our team examines the value propositions of several telehealth providers as the industry enters the next stage of growth.
HawkPartners developed a five-step framework to help pharma companies anticipate the “new normal” as a means of optimizing HCP engagement in a post-COVID-19 world.
With the growing trend of real-world data and real-world evidence in healthcare, what can we expect moving forward? Sharon Mowen explores these applications across the product life cycle and what it means for the future of healthcare decisions.
Statistics and investments point to pharma companies’ integration of transformative technologies into ways of thinking and doing business. The infographic below, developed by Abbey Ahearn and Lucy Hale, demonstrates the rising emphasis of digital health in pharma.
Amidst explosive investment in digital health, the industry is working to keep the human side of care front and center.
Digital health offers tremendous upside for the pharmaceutical industry. In this infographic, we explore the challenges and opportunities ahead for pharma as it innovates to move closer to fully digitized healthcare.
Abbey Ahearn shares her vision on the (near-term) future of consumer healthcare. Pills with sensors, digital therapeutics for addiction, and AI for early cancer detection are just a few of the coming innovations.